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Abstract
Background: Cardiovascular diseases (CVD) are the leading cause of death and the third cause
of disability in Europe. Prevention programmes should include interventions aimed at a reduction
of medical risk factors (hypertension, hypercholesterol, hyperglycemia, overweight and obesity) as
well as behavioural risk factors (sedentary lifestyle, high fat intake and low fruit and vegetable intake,
smoking). The aim of this study is to investigate the effects of a multifaceted, multidisciplinary
electronic prevention programme on cardiovascular risk factors.
Methods/Design: In a randomized controlled trial, one group will receive a maximal intervention
(= intervention group). The intervention group will be compared to the control group receiving a
minimal intervention. An inclusion of 350 patients in total, with a follow-up of 3 years is foreseen.
The inclusion criteria are age between 25–65 and insured by the Onderlinge Ziekenkas, insuring
for guaranteed income in case of illness for self-employed. The maximal intervention group receives
several prevention consultations by their general practitioner (GP) using a new type of
cardiovascular risk calculator with personalised feedback on behavioural risk factors. These
patients receive a follow-up with intensive support of health behaviour change via different
methods, i.e. a tailored website and personal advice of a multidisciplinary team (psychologist,
physiotherapist and dietician). The aim of this strategy is to reduce cardiovascular risk factors
according to the guidelines. The primary outcome measures will be cardiovascular risk factors. The
secondary outcome measures are cardiovascular events, quality of life, costs and incremental cost
effectiveness ratios. The control group receives prevention consultations using a new type of
cardiovascular risk calculator and general feedback.
Discussion: This trial incorporates interventions by GPs and other health professionals aiming at
a reduction of medical and behavioural cardiovascular risk factors. An assessment of clinical,
psychological and economical outcome measures will be performed.
Trial registration: ISRCTN23940498
Background
In Europe, cardiovascular disease (CVD) is the leading
cause of death (1.5 million deaths per year) and is an
important source of disability [1-3]. The incidence of cor-
onary vascular events is 1.91 per 1000 population years
[4]. It is proven that prevention of CVD risk factors lead to
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a reduction of CVD[5,6]. Prevention programmes should
include interventions aimed at a reduction of medical risk
factors (hypertension, hypercholesterolaemia, hypergly-
caemia and overweight) and behavioural risk factors (sed-
entary lifestyle, high fat intake and low fruit and vegetable
intake, smoking) for CVD[7,8] The individual contribu-
tions of these risk factors to CVD are: high blood pressure
(62%), high cholesterol (18%), overweight (13%), low
fruit and vegetable intake (11%), physical inactivity (7%),
tobacco (12%) and alcohol (4%). The joint contribution
of these risk factors is 70–76%[9]. Recent guidelines
advise to determine the overall risk on CVD using the
SCORE Model, scoring the individual risk in terms of the
absolute 10 year probability of developing a fatal cardio-
vascular event[3]. Furthermore, treatment should be tar-
geted to all medical and behavioural risk factors i.e.
stimulating physical activity, aiding healthy food choices
and encouraging non-smoking[3,10]. Online health
advice instruments can be used as a tool to aid behav-
ioural change[11]. The implementation of prevention
programmes has to be cost effective. Reduction of cardio-
vascular risk factors seems to be cost effective [12-14]. To
conclude, it is important to implement cost effective CVD
prevention programmes to decrease CVD (risk factors)
and associated costs[3]. The aim of the PreCardio-study is
to determine the effects of a computer-tailored cardiovas-
cular prevention programme with the general practitioner
(GP) as a key figure. This prevention programme consists
of interventions targeted at all risk factors with the use of
information and communication technology (ICT) at dif-
ferent levels. At GP-level, a tool for computer-assisted car-
diovascular risk screening and an informational website
will be implemented. At patient-level, a personalised web-
site with tailored advice will be foreseen.
Methods/Design
Study population
PreCardio is a randomized controlled trial. Approval was
obtained from the ethics committee of the University Has-
selt. A total of 350 subjects will be included in the study
with a follow-up of 3 years. The inclusion criteria are age
between 25–65 and insured by the Onderlinge Ziekenkas,
insuring for guaranteed income in case of illness for self-
employed. All study participants need to sign an informed
consent and have access to the internet. Other eligitability
criteria are not included.
Recruitment
The study participants will be recruited through various
channels. Firstly, all potential participants are insured by
"De Onderlinge Ziekenkas". This membership gives the
study secretariat access to necessary contact information.
Secondly, all of the insured are self-employed, most of
them lawyers. This provides the study office with two
advantages: (1) communication is possible at the worksite
and (2) the prevention programme is even more tailored
to the uniform target group. The announcement of the
study was already made through mass-media announce-
ment (e.g. national newspapers, provincial journal and
radio) but will be intensified at the worksites of the poten-
tial participants. Together with the involved Bars (of the
province of Limburg in the East of Belgium) mass mail-
ings and promotional activities at the worksite (e.g. infor-
mation, fruit distribution,) will be organized. Thirdly, a
large event will be organised for the participants of the
intervention group and control group. Before joining
these events a written informed consent, downloadable
on a website with brief information, should be signed and
mailed back to the study secretariat. At this large event
general information about PreCardio will be given, a first
screening and the ability to purchase health-related prod-
ucts.
The general practitioners (GP) that will participate in the
study are GPs of the province of Limburg, situated in the
East of Belgium. They will be recruited with involvement
of their own provincial general GP platform "Limburgs
Huisartsenplatform" and provincial institutions involved
in health "LOGOs". Together with the GP platform and
the LOGOs mass mailings to GPs of Limburg will be
organised. Moreover, minimal two information sessions
for GPs will be organised in the university building with
information about the study and education about a new
type of cardiovascular risk calculator will be offered. All
participating GPs need to sign an informed consent and
have access to the internet for downloading an electronic
cardiovascular risk screenings programme based on the
European Guidelines for CVprevention[3].
Randomization
The study participants were randomized using a nonstrat-
ified randomization technique with a known probability.
Each participant had a 67% chance to be allocated to the
intervention group. The randomization was performed by
an independent person. The names of the participants
were written on papers that were put in sealed envelopes.
Next, the envelopes were randomly assigned by hand to
two baskets for the intervention and the control group,
respectively, with a ratio of 2/1.
Overall aim of the study
To examine the effects of medical and behavioural inter-
ventions on medical cardiovascular risk factors such as
hypertension, hypercholesterolaemia and hyperglycaemia
and behavioural risk factors such as a sedentary lifestyle,
an unhealthy diet and smoking. Furthermore, the impact
of changes in medical and behavioural risk factors on
overall cardiovascular risk will be investigated.BMC Cardiovascular Disorders 2007, 7:27 http://www.biomedcentral.com/1471-2261/7/27
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Primary aims
1. To examine the effects of medical and behavioural
interventions on medical parameters such as systolic
blood pressure, diastolic blood pressure, total blood cho-
lesterol level, blood glucose level (HbA1c), overweight
and obesity, BMI.
2. To examine the effects of medical and behavioural
interventions on health related behaviour such as physical
activity; fat; fruit and vegetable intake; and smoking
behaviour.
3. To examine the effects of medical and behavioural
interventions on overall cardiovascular risk mediated by
changes in medical and/or behavioural risk factors.
4. To determine the proportion study participants with a
10% reduction in systolic blood pressure with partici-
pants with hypertension
5. To determine the proportion study participants with a
10% reduction in diastolic blood pressure with partici-
pants with hypertension
6. To determine the proportion study participants with a
10% reduction in total cholesterol with patients with
hypercholesterol
7. To determine the proportion study participants with a
10% reduction in HB1Ac with initial HB1Ac >7% (high
risk)?
8. To determine the proportion study participants with a
10% reduction in weight with initial BMI >25 kg/m2?
Secondary aims
1. To determine the incidence of cardiovascular events
2. Number and total costs of cardiovascular events leading
to loss of productivity
3. To examine the effects of medical and behavioural
interventions on psychological constructs as stage of
change, attitude towards behaviour, self-identity, per-
ceived behavioural control, autonomous motivation,
intention.
4. To examine the effects of medical and behavioural
interventions on Health Related Quality of Life.
5. To examine the effects of social support on health
related behaviour (physical activity, fat and fibre intake
and smoking behaviour) and psychological constructs
(stage of change, attitude towards behaviour, self-identity,
perceived behavioural control, autonomous motivation,
intention)
6. To perform a cost-effectiveness analysis of the medical
and behavioural interventions using incremental cost-
effectiveness ratios
Design
The intervention group as well as the control group
receive a first medical prevention consultation with a GP
of their choice. Fig 1 represents the study design. The GP
performs a cardiovascular risk assessment using an
adapted risk assessment flowchart (Fig 2). Medical data
such as systolic and diastolic blood pressure, total blood
cholesterol, LDL cholesterol (and HbA1c) are collected at
this medical prevention consultation prior to risk deter-
mination. The intervention and the control group receive
the therapeutic goals from the risk assessment flowchart.
The intervention group receives supplementary tailored
feedback regarding behaviour change based on the Tran-
sTheoretical Model or the Stages of Change Model[23].
Thus, the feedback is tailored to the stage of change the
study participants are in for physical activity, diet and quit
smoking. After the first medical prevention consultation
all study participants get access to a website which
includes a question list for baseline data collection. The
intervention group receives tailored advice on this ques-
tion list. The control group receives general advice to
impede or avoid drop-out but with caution for causing
bias. The question list includes items for physical activity
assessment, fat intake assessment, fruit and vegetable
intake assessment, smoking behaviour assessment and
assessment of psychological variables. The physical fitness
will be determined at the GP's office, at study participants
home and at baseline data collection during the large
event. For follow-up data collection these assessments will
take place regularly. The intervention group receives the
PreCardio design Figure 1
PreCardio design. GP: general practitioner.BMC Cardiovascular Disorders 2007, 7:27 http://www.biomedcentral.com/1471-2261/7/27
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maximal intervention and the control group receives the
minimal intervention.
Study measurements
The study measurements in the PreCardio-study include
cardiovascular risk assessment. Supplementary a ques-
tionnaire assessing physical activity; fat, fruit and vegeta-
ble intake; smoking behaviour and psychological
variables will be filled out. Furthermore, physical fitness
assessment will be performed. These assessments will take
place at certain times during the 3 year follow up of the
study (Table 1).
Cardiovascular risk assessment
Cardiovascular risk assessment will be based on the
SCORE risk table (Fig 3) [15]. The overall cardiovascular
risk score is the 10-year risk to die from CVD. According
to SCORE a risk score of 4% or more is considered a high
risk. A risk score in the range 2%–4% is considered a
medium risk and a score lower than 2% is seen as a low
risk[3]. The medical and behavioural advices following
risk assessment are adapted from the Boland algo-
rithm[16]. Cardiovascular risk assessment in the PreCar-
dio-study is thus an adaptation of existing and validated
risk assessment flowcharts in Belgium (Fig 2).
Physical activity assessment
For physical activity assessment it is important that each
study participant gives an estimate of the intensity, dura-
tion and frequency of the physical activity he has in daily
life. For this purpose a Dutch translation and computer-
ized version of the International Physical Activity Ques-
tionnaire (IPAQ) was chosen[17]. This computerized
version was found to be reliable and reasonably valid
physical activity assessment tool for the general Belgian
adult population[11].
Fat intake assessment and fruit and vegetable intake assessment
To stimulate rapid assessment only data collection will be
limited to fat intake and fruit and vegetable intake. For fat
intake assessment a computerized fat intake question-
naire with a good reliability and adequate validity was
chosen[18]. For fruit and vegetable intake a short food-
frequency questionnaire was used with a good test-retest
reliability (Spearman r from 0.45 to 0.77), and adequate
validity comparing the food-frequency questions with 7-
day food records (Spearman r from 0.38 to 0.53)[19].
Smoking behaviour assessment
To obtain data about smoking behaviour, a short ques-
tionnaire regarding smoking from a national health ques-
tionnaire used by the federal government was
selected[20]. This questionnaire includes questions for
smokers as well as for former smokers.
Quality of life assessment
The Dutch translation of the Short Form 36 (SF-36) will
be used to measure Health Related Quality of Life
(HRQoL). This version was successfully tested in a Belgian
and Dutch population with a Chronbach's alpha coeffi-
cient ranging from 0.81 to 0.91[21,22].
Assessment of psychological variables
Stages of change
Stages of change is a construct from the TransTheoretical
Model[23]. The stages of change were assessed using a sin-
gle table for assessing physical activity, diet and quitting
smoking (Table 2). The formulation of the statements was
based on the remarks about standardization in a recent
meta-analysis[24] and questionnaires for measuring
stages of change for physical activity[25] and fat
intake[18].
SCORE risk table [15] Figure 3
SCORE risk table [15].
Adapted risk assessment flowchart [3, 16] Figure 2
Adapted risk assessment flowchart [3, 16].BMC Cardiovascular Disorders 2007, 7:27 http://www.biomedcentral.com/1471-2261/7/27
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Attitudes towards behaviour change
Attitudes are an important element in the Theory of
Planned Behaviour[26]. As recommended by Ajzen and
Fishbein[27], a measure of attitude towards the target
behaviour was obtained using 3 evaluative semantic dif-
ferential scales. Study participants are asked to assign a
value along a 7-point scale between opposing evaluative
adjectives (e.g. pleasant-unpleasant, good-bad, relaxing-
stressing)[28]. An example of an item requesting a value
assignment for "To eat low fat every day for me is" along
a 7-point scale between the opposing evaluative adjectives
"pleasant" and "unpleasant".
Self-identity towards behaviour change
Self-identity is seen as the extent to which people see them
fulfilling different societal roles[28]. In this study it is seen
as the way people define themselves regarding a specific
health behaviour (physical activity, a healthy diet and
quitting to smoke). The question list includes 2 items for
self-identity for each type of health behaviour. An item for
physical activity is, for example, "I think of myself as
someone who is physically active". An item for diet is, for
example, "I am someone who often thinks about the
importance of a healthy diet for my health". For smoking,
an item for self-identity is, for example, "I am someone
who thinks quitting to smoke is important". All were
measured on 7-point Likert scales, anchored by strongly
disagree-strongly agree.
Perceived control over behaviour
Perceived control over behaviour is related to self-efficacy,
the two variables are significantly and highly correlated
[29]. However, if the two variables are entered into a
regression model for behavioural intention, they contrib-
ute independently to the model. Perceived behavioural
control is usually measured in terms of difficulty or ease
of performing the behaviour. This means that behaviours
that are not under individuals' full volitional control are
included [29]. Perceived control over behaviour is meas-
ured with 1 item. Participants indicate the extent to which
they agreed with each item on 7-point Likert scales from
strongly disagree-strongly agree. The items include "I have
the feeling that daily 30 min moderate PA or 3 times
sports a week is completely in my control the next
month", and " I have the feeling that quitting to smoke is
completely in my control the next month". The selection
of these items was based on prior research with this con-
cept regarding health-related food choice[28].
Self-efficacy
Self-efficacy is usually measured in terms of individuals'
confidence in their ability to perform the behaviour [29].
Self-efficacy is measured with 2 items for each type of
health behaviour. Participants rated these items using a 7-
point Likert scale, anchored by strongly disagree-strongly
agree. The items include "I am capable to adopt daily PA
for 30 minutes or sport 3 times a week in the next month,
also on days I feel bad, tired, stressed or depressed", "I
think I am capable to adopt a low fat diet in the next
month, also on days that I am very busy or family and
friends request extra time from me" and "I am capable to
quit smoking the next month, also on days I feel bad,
tired, stressed or depressed". The items for self-efficacy
were based on prior research with this concept regarding
health-related food choice[28].
Table 1: Data collection
Assessment of Instrument Means 0 m 4 m 6 m 8 m 12 m 18 m 24 m 30 m 36 m
Cardiovascular risk (BMI, 
blood pressure, cholesterol, 
HBA1c)
Risk Calculator GP YES ~RISK NO ~RISK YES NO YES NO YES
Physical Activity (PA) IPAQ Website YES NO YES NO YES YES YES YES YES
Fat intake Questionnaire Website YES NO YES NO YES YES YES YES YES
Fruit & Vegetable intake Food Frequency 
Questionnaire
Website YES NO YES NO YES YES YES YES YES
Smoking behaviour Questionnaire Website YES NO YES NO YES YES YES YES YES
HRQol SF-36 Website YES NO YES NO YES YES YES YES YES
Stages of change Questionnaire Website YES NO YES NO YES YES YES YES YES
Attitudes 12 items Website YES NO YES NO YES YES YES YES YES
Self-identity 6 items Website YES NO YES NO YES YES YES YES YES
Perceived control over 
behaviour
3 items Website YES NO YES NO YES YES YES YES YES
Self-efficacy 6 items Website YES NO YES NO YES YES YES YES YES
Social Support 15 items Website YES NO YES NO YES YES YES YES YES
Physical fitness Step test Event/GP/
home
YES NO NO NO YES NO YES NO YESBMC Cardiovascular Disorders 2007, 7:27 http://www.biomedcentral.com/1471-2261/7/27
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Autonomous motivation for behaviour change
People are autonomously motivated if they experience a
true sense of volition and choice and act because of the
personal importance of the behaviour [30,31]. If people
are autonomously motivated the behaviour they perform
is said to be autonomously regulated. Autonomous regu-
lation is assessed with the Treatment Self-Regulation
Questionnaire [31]. The Treatment Self-Regulation Ques-
tionnaire was used in former research on the effect of an
intervention on diet and smoking cessation [31]. For
assessing autonomous motivation for physical activity the
Behavioural Regulation Exercise Questionnaire II (BREQ-
II) was chosen for the measurement of autonomous moti-
vation, with good psychometric properties[32,33].
Intention towards behaviour change
Intention to engage in a behaviour is a direct precursor to
engaging in the behaviour itself [29]. Behavioural inten-
tion was assessed using 3 items: "I plan to adopt a healthy
diet (low on fats and 5 portions of fruit or vegetables) in
the next month", "I plan to adopt daily PA or 3 times sport
a week in the next month" and "I plan to quit smoking in
the next month". The 3 items could be answered using a
7-point Likert scale, with endpoints labelled strongly dis-
agree-strongly agree. These items were based on previous
research [30].
Social support
Social support is an important variable influencing behav-
iour change[34]. Consequently, several items were
included in the question list to measure the amount and
nature of experienced social support of the study partici-
pants. The answer possibility involved a 3-point Likert
scale with following options: never/almost never, some-
times and often. The items included how often people feel
encouraged by partner support, support of children older
than 12, support of family or friends, support of col-
leagues, support by GP and support by the PreCardio-
team for adopting a healthier diet, being more physically
active and quitting smoking. Furthermore, study partici-
pants are asked if they have a fixed sports partner with
answer possibilities: yes, sometimes and no.
Assessment of physical fitness
A step test will be used for assessment of physical fitness.
The step test procedure used was modified from earlier
procedures[35]. The step test consisted of stepping up and
down a platform at a constant controlled by a metronome
(90 beats per minute). Each beat initiates the movement
of one leg up or down the platform. The stepping period
lasted for 5 minutes. The height of the platform was deter-
mined according to patients' height and risk for complica-
tions (e.g. former personal ischemic event). For
individuals smaller than 160 cm or with a former event a
platform of 25 cm was used. For individuals with a height
between 160 and 180 a platform of 33 cm was used. For
people with a height above 180 cm a platform of 40 cm
was used. The heart rate frequency was recorded between
1 minute and 1:30 minutes after completing the step test
or stop because of exhaustion) in sitting position,
between 2 minutes and 2:30 and between 3 minutes and
3:30. With a formula, the physical fitness level of the
patient can be calculated. Few materials are needed in
order to execute this test: a platform with a specific height,
a stopwatch, and a metronome in order to determine the
stepping speed.
Interventions
Minimal intervention
Medical prevention consultation
The interventions targeted on medical parameters include
a first medical prevention consultation with the GP. In
this medical prevention consultation the cardiovascular
risk (risk on having a heart attack in the next 10 years) will
be calculated using a new computer programme. This
computer programme is called "Electronic Prevention
Record" (EPR). Innovative about the EPR is its connection
to "Electronic Medical Record" (EMR). The EMR is also a
computer programme, a record about the medical history
and treatment provided to the patient. In the province of
Limburg, the setting for the PreCardio-study, 75% of the
GPs use an EMR[36]. In Belgium, 70% of the GPs use an
EMR [37]. In Belgium there are 17 different providers of
EMRs. The EPR generates, after a limited input (thanks to
the connection to the EMR), the cardiovascular risk, the
therapeutic goals (targeted on medical parameters and
behaviour change) and a target date for the next follow-up
consultation. This date is dependent on the determined
cardiovascular risk. During these medical prevention con-
sultations medical practice will be performed: measure-
ment (e.g. blood pressure) and installation of treatment
to influence medical parameters. Supplementary, the GP
performs stage of change assessment (Table 2) using the
EPR. The GP asks for PA and diet which statement fits the
participant's situation best. If it is a smoker, the stage of
change for quitting smoking is assessed as well. The stage
of change assessment is for the control group not followed
by tailored feedback for behaviour change.
All data collected at the medical prevention consultation
are stored in the EPR that is connected to the EMR (Fig 4).
Therapeutic goals in line with cardiovascular risk are
determined. These goals, together with the data provided
by the study participant are electronically sent to the study
office by a secured connection. The information from the
intervention group is closely examined and the partici-
pants of the intervention group will receive a reminder
from the study office when it is time to plan their next
medical prevention consultation.BMC Cardiovascular Disorders 2007, 7:27 http://www.biomedcentral.com/1471-2261/7/27
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Website with minimal information
The website available for the control group is limited and
contains information about the minimal intervention
(i.e. medical prevention consults without tailored feedback
and without reminder from study office). It is also used as
a means for study measurements at certain times during
the 3-year follow up (Table 1). This limited website con-
tains general feedback after the questionnaire with multi-
ple assessments has been filled out by the study
participants from the control group. This general feedback
(= not tailored) is about physical activity, fat intake and
smoking and is modified for different measurements in
time to avoid drop-out. However, the advice will always
be formulated very abstract to avoid 'contamination' of
the control group as was the case in another multiple risk
factor cardiovascular intervention study[38].
Maximal intervention
Medical prevention consultation + tailored feedback + reminder 
from study office
The maximal intervention includes the medical preven-
tion consultation described under the minimal interven-
tion. However, the maximal intervention includes two
extra services in relation to the medical prevention consul-
tation.
Firstly, supplementary to the therapeutic goals which are
communicated to the patient, the intervention group
receives tailored feedback according to the stage of change
the study participant is in. For this purpose, the table to
for stage of change assessment (Table 2) is included in the
EPR. The GP asks for PA and diet which statement fits the
participant's situation best. If it is a smoker, the stage of
change for quitting smoking is assessed as well. Following
this stage determination, the GP gets information about
the stage of change the study participant is in for each
behaviour, namely: precontemplation, contemplation,
preparation, action or consolidation[23]. The tailored
feedback that follows is also based on principles from
Motivational Interviewing (MI) [39]. Tailored feedback
following a classification in the contemplation stage for
smoking gives the GP following information: "Accept and
talk about the ambivalence of the patient regarding quit-
ting to smoke"; "Talk with the patient about the advan-
tages and disadvantages of smoking and quitting
smoking. Don't give arguments to quit smoking yourself";
"Advise the patient to download the quitting to smoke
leaflet on the personalised website"; "Advise the patient to
look at step 1 and step 2 of the quitting to stop manual on
the personalised website". Tailored feedback can be easily
printed and given along with the participant by the GP.
This printed tailored feedback for the participant follow-
ing a classification in the contemplation stage for smoking
contains following information: "You want to quit smok-
ing and you know it could have advantages, but some-
thing keeps you from actually quitting"; "It can be a good
idea to think about the advantages and disadvantages of
smoking and quitting to smoke. The quitting to smoke
manual (step 1 and step 2) on the website can be an aid
in this process"; "You can also download a quitting to
smoke leaflet". This kind of advice is given to every study
participant in the intervention group for all relevant
health behaviours.
Secondly, the intervention group receives the supplemen-
tary service of being reminded of their next follow-up pre-
vention consult by the study office. As mentioned above,
this target date is dependent on the cardiovascular risk of
the participant. This reminder will be send by mail or the
patient will be reminded by telephone.
Personalised Website with tailored feedback
The intervention group gets access to a personalised web-
site with tailored feedback based on questionnaires. Fig 5
shows the site plan of the personalised website. This web-
site is supposed to aid people with behaviour change. The
content is based on specific theories on behaviour change,
such as the TTM[23,40], Self-Determination Theory (SDT)
[30] and Theory of Planned Behaviour (TPB)[26]. Fur-
thermore, operant learning principles (e.g. stimulus con-
trol, contingency management), principles from
behavioural cognitive therapy (e.g. decisional balances,
problem-solving techniques) and relapse prevention tech-
niques are used as a basis for the content of the website, in
particular for the manuals [40,41].
Data transfer Figure 4
Data transfer.BMC Cardiovascular Disorders 2007, 7:27 http://www.biomedcentral.com/1471-2261/7/27
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The personalised website contains tailored feedback after
the questionnaire with multiple assessments has been
filled out by the study participants. This tailored feedback
regarding physical activity and fat intake is borrowed from
previous research with proven efficacy and completely
integrated in the website [11,18]. Moreover, more exten-
sive tailored feedback on other assessment measures (e.g.
stage of change, autonomous motivation for PA) is given
in the different files on the website (PA file, Food File,
Stop smoking File). In the General overview all activity
from the patient and results are summarised. The General
overview contains several extra's, namely: short links to
the PA diary, Food diary and Stop smoking diary; results
from medical prevention consultations and a personal
calendar with important dates (target date for follow-up
medical prevention consultation, start dates for behaviour
change). On the homepage and in the Files (Cardio File,
PA File, Food File and Stop smoking File) personal mes-
sages for each participant can be given. The message could
be, for instance, an encouragement for behaviour change,
an answer to a question of the participant or an
announcement for an initiative of importance for the par-
ticipant (e.g. group counselling for smoking-cessation).
On the forum on the homepage participants can post
messages, communicate with each other and ask ques-
tions to the PreCardio-team. The PreCardio-team guaran-
tees answers concerning cardiovascular prevention and
behaviour change. If the PreCardio-team can't provide an
answer, other specialists will be consulted to provide an
answer to the study participants. Of course, people can
Site plan of the personalised website (maximal intervention) Figure 5
Site plan of the personalised website (maximal intervention). PA: Physical Activity.
First time login?
or 
Time for assessment? 
Downloads 
Food File 

NO
Questionnaire data 
collection 
Home page 
 Tailored PA advice 
Tailored Fat Intake advice 
Files
Cardio File 

PA File 

General overview 
Forum
Siteplan
Contact us 
Stop smoking File 

Information
Risk calculator
Information
Step test
Stage of change
Motivation test
Manual: 
Step 1: Temporary PA: step test + PA diary (2 weeks of registration) 
Step 2: (Dis)advantage of change/status quo: decisional balance 
Step 3: Plan your future PA: minimove programme, reduce my risk programme (fitness 
programme), strengthening programme, start to programmes, run a marathon 
Step 4: Relapse prevention: design your own relapse chain 
Step 5: Search social support 
Step 6: Determine a start date 
Step 7: PA diary for follow-up with goal-testing per programme 
Fitness programme
Stengthening programme
Minimove
Contact behaviour coach
BMI calculator
Information
Food tests
Manual: 
Step 1: Temporary food pattern: food tests + diary
Step 2: (Dis)advantage change/status quo: dec. balance
Step 3: Plan your future food pattern: food triangle
Step 4: Relapse prevention: relapse chain
Step 5: Search social support
Step 6: Determine a start date
Step 7: Food tests + diary for follow-up
Energy need calculator
Waist-height calculator
Contact behaviour coach
Stage of change
PA diary
Food diary
Recipes
Information
Dependency test
Stage of change
Contact behaviour coach
Manual: 
Step 1: Temporary smoking pattern: smoking diary 
Step 2: (Dis)advantage change/status quo: dec. balance 
Step 3: Relapse prevention: relapse chain 
Step 4: Search social support  
Step 5: Determine a date to quit smoking 
Introduction page with login possibility
YES BMC Cardiovascular Disorders 2007, 7:27 http://www.biomedcentral.com/1471-2261/7/27
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find all contact information of the PreCardio-team (study
office) in the section "Contact us".
The PA file contains several PA programmes with different
difficulty levels. The easiest programme is "Minimove",
this is a programme with mainly tips for improving PA
through (Nordic) walking aiming at a health benefit. The
programme most in line with the PreCardio mission,
namely CVD prevention, is the "Reduce my risk" pro-
gramme. This programme is a fitness programme aimed at
improving physical fitness through more intensive PA.
The basis for the fitness programme is a specially devel-
oped algorithm linked to the step test used in the study
(Fig 6). Three different training programmes are advised,
according to step test score determined by physical fitness
assessment.
Support from multidisciplinary team
Next to the personalised website with tailored feedback,
study participants of the intervention group are entitled to
support from a multidisciplinary team. This multidiscipli-
nary team includes: a cardiologist, a general practitioner,
a psychologist, a physiotherapist and a dietician. Different
media will be available for this personal contact: personal
messages on the website, the forum on the website, e-
mail, telephone and group sessions. The first types of
media will be more frequently used than the latter,
dependent on the stage of behaviour change patients are
in. Moreover, the cost-effectiveness of the prevention pro-
gramme must be guarded. The psychologist (= behaviour
coach) can aid people more thoroughly with behaviour
change, using the different manuals and behavioural
(cognitive) therapy.
GP intervention
At GP-level a tool for computer-assisted cardiovascular
risk screening (EPR) will be implemented. Minimal two
information sessions for GPs will be organised in a uni-
versity building with information about the study and
education about the EPR. GPs will have access to an infor-
mational website. This informational website contains
information about CVD prevention in general with a sum-
mary of the latest guidelines (also in a newsletter sent by
mail). (Moreover, relevant articles will be provided to the
GPs in PDF-format). Furthermore, it contains informa-
tion about the PreCardio-study and the role of the GP in
the study. On this website information about the EPR will
be available (installation, how to use, background). GPs
are provided with information on behaviour change,
including video registrations of motivational interviewing
adaptations for PreCardio. In the section on behaviour
change more information will be given about the stages of
change and type D-personality as a risk factor for CVD.
The website for GPs also contains an overview of the per-
sonalised website for patients from the intervention
group. GPs have access to a forum where they can post
messages to open a debate with their participating col-
leagues about CVD prevention or the PreCardio-study or
messages with a question for the PreCardio-team. In other
sections contact information and links to relevant web-
sites can be found.
Analysis and power
A power calculation was performed to determine the
number of study participants needed to detect a signifi-
cant effect of the PreCardio prevention programme. A t-
test will be used to compare the means of the outcome
measures from the intervention and the control group.
The sample size calculation is based on the population
standard deviation of the primary outcome measure. For
PreCardio, this is, for instance, systolic blood pressure.
Kelley et al found a mean systolic blood pressure of 125
mm/Hg (SD 14 mm/Hg)[42]. The sample size calculation
was performed with Nquery Advisor 4.0®. A two group t-
test with a 0,05 two-sided significance level will have 82%
power to detect the difference between a Group 1 mean of
120 mm/Hg and a Group 2 mean of 125 mm/Hg, a differ-
ence in means of -5 mm/Hg, assuming that the common
standard deviation is 14 mm/Hg, when the sample sizes
in the two groups are 200 and 100, respectively (a total
Table 2: Assessment of stages of change
30 minutes of moderate PA 
daily or 3*/week intensive PA
Low fat diet and 5 portions 
fruit and vegetables daily
Not smoking (if relevant)
I'm not performing the behaviour and I do not 
intend to in the next 6 months
I'm not performing the behaviour but I plan to in 
the next 6 months
I'm not performing the behaviour but I plan to in 
the next 30 days
I perform the behaviour but no longer than 6 
months
I perform the behaviour but already longer than 6 
monthsBMC Cardiovascular Disorders 2007, 7:27 http://www.biomedcentral.com/1471-2261/7/27
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sample size of 300). Other outcome measures were also
used to determine the necessary sample size. A recent
study about the effect of a computer-tailored intervention
to reduce fat intake included at post-test a mean fat intake
of 85 grams/day (SD 34.5 grams/day) [43]. A two group t-
test with a 0,050 two-sided significance level will have
80% power to detect the difference between a Group 1
mean of 85 grams/day and a Group 2 mean of 97 grams/
day, a difference in means of -12 grams/day assuming that
the common standard deviation is 34.5 grams/day, when
the sample sizes in the two groups are 200 and 100,
respectively (a total sample size of 300). Another study
evaluating a website-delivered computer-tailored inter-
vention for increasing physical activity increased physical
activity with a mean of 77 minutes in the intervention
group [44]. In this study the total moderate- and vigorous-
intensity physical activity was chosen as an outcome
measure. This measure can be used to determine the nec-
essary sample size to detect a difference in means in the
present study. At follow up this measure had a mean of
363 minutes (SD 323) for the intervention group and 241
minutes (SD 269) for the control group [43]. A two group
t-test with a 0,05 two-sided significance level will have
86% power to detect the difference between a Group 1
mean of 363 minutes and a Group 2 mean of 241 min-
utes, a difference in means of 122 minutes, assuming that
the common standard deviation is 323 minutes, when the
sample sizes in the two groups are 200 and 100, respec-
tively (a total sample size of 300).
A linear regression model will be employed to assess the
effects of the prevention programme on change in overall
cardiovascular risk from baseline to 3 year follow-up.
Cost and cost effectiveness analysis
Cost analysis
Next to an effect evaluation a cost analysis will be per-
formed. There are different costs that will be measured in
the PreCardio-study: (1) One-time costs, this is the total
cost for the implementation of the prevention programme
(e.g. construction costs of personalised website); (2) Costs
for medical resource use (e.g. drug costs, laboratory costs,
primary prevention consults); (3) Continuous costs:
(acute care) costs for CVD, costs for CVD morbidity and
mortality, hospitalization costs (4) Administration costs;
(5) Personnel costs (PreCardio-team, other profession-
als); (6) Travelling and time costs (e.g. study participant's
time and GP time); (7) Indirect costs due to productivity
loss; (8) Material costs and overhead. This study will be
performed from a health service perspective.
Cost effectiveness analysis
In cost effectiveness analysis incremental cost-effective-
ness ratios (ICER) are used as an economic outcome
measure. An ICER can be calculated as incremental cost
divided by incremental effectiveness [45]. Incremental
cost is calculated as total cost for the treatment pro-
gramme minus total cost for the comparison programme.
Incremental effectiveness can be calculated as Quality
Adjusted Life Years (QALYs) gained by the treatment pro-
gramme minus QALYs gained by the comparison pro-
gramme. This is life expectancy adjusted by utility, a
Algorithm for fitness programme "Reduce my risk" (maximal intervention) Figure 6
Algorithm for fitness programme "Reduce my risk" (maximal intervention).BMC Cardiovascular Disorders 2007, 7:27 http://www.biomedcentral.com/1471-2261/7/27
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measure of quality of life[46]. In the PreCardio-study
ICERs will be determined. A specific type of cost-effective-
ness analysis, a cost-utility analysis, will be performed,
using QALYs as a measure of effects. Inspired by a compa-
rable study of Munro et al., SF-36 data were converted
using a specific algorithm into health state utility values
for the determination of incremental QALYs[47,48].
Discussion
The PreCardio-study is a randomized controlled trial.
However, the shared worksite setting could lead to an
intervention contamination. In this regard, the failure to
find significant effects from the Heartbeat Wales pro-
gramme due to contamination of the reference area is rel-
evant[38]. Partially, this study is similar to the PreCardio-
study since it compares the effects of a multiple risk factor
intervention. However, the multiple risk factor interven-
tion from the "Heartbeat Wales" programme was less
individually tailored, didn't include GPs as key figures,
offered no multidisciplinary support and made no use of
modern information technology like a personalised web-
site for participants of the study. The benefits of these
interventions targeted at behavioural risk factors could be
substantial. After all, the PREMIER study, a clinical trial of
comprehensive lifestyle modification for blood pressure
control, was already effective in reducing cardiovascular
disease risk [49]. This study is similar to the PreCardio-
study because it targets one of the medical risk factors for
cardiovascular disease. However, in the present study
other risk factors will be targeted as well leading to a
reduction in the overall cardiovascular risk.
Several aspects of the PreCardio-study are noteworthy.
Firstly, all interventions are based on recent guidelines
and knowledge on CVD prevention. Moreover, this
knowledge was taken as a basis to develop a new compu-
ter programme for GPs. After limited input, this pro-
gramme automatically determines CVD risk and generates
therapeutic goals according to this risk. Furthermore, tai-
lored advice is provided to the study participant. The
involvement of GPs in the PreCardio-study is paramount.
Secondly, study participants are provided with a number
of aids to support them with behaviour change. These
include a personalised website with tailored feedback and
personal support from a multidisciplinary team. Conse-
quently, a reduction in medical and behavioural risk fac-
tors resulting in a reduction in overall CVD risk is
expected.
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